Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. olfactomics surgery

Olfactomics Surgery SIGNED

BRINGING SURGERY TO THE 21ST CENTURY: REAL-TIME TISSUE ANALYSIS DURING CANCER SURGERY. Improving Patient Safety, Quality and Cost-Effectiveness

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Olfactomics Surgery project word cloud

Explore the words cloud of the Olfactomics Surgery project. It provides you a very rough idea of what is the project "Olfactomics Surgery" about.

analyze    hospital    intestinal    easily    invasive    cancer    society    13    2015    850m    optimal    connections    spinoff    workplaces    300    follow    industry    benefits    reoperation    900m    impacts    2019    oy    currently    financials    applicable    saved    launched    prostate    preoperative    excellent    reachable    breakthrough    women    revenue    surgical    health    trend    care    sparing    founded    specialties    instrumentation    consists    examination    smoke    compromising    000m    market    100m    skin    healthcare    rate    solution    innovative    law    effectiveness    tissue    software    removal    life    200    2027    commercial    minimally    postoperative    imaging    noninvasive    sensor    sold    impaired    savings    60    specialists    direct    quality    additional    surgeon    operated    surgeries    international    medical    incomplete    performed    pathological    team    time    data    clinical    commercialize    first    workflow    breast    olfactomics    removed    patient    company    tumor    university    global    surgery    operation    ranges    trl    finnish    device   

Project "Olfactomics Surgery" data sheet

The following table provides information about the project.

Coordinator		 OLFACTOMICS OY 

Organization address
address: AAKKULANKATU 4 C 9
city: TAMPERE
postcode: 33700
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Finland [FI]
 Total cost 2˙649˙375 €
 EC max contribution 1˙854˙562 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-04-01   to  2021-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OLFACTOMICS OY FI (TAMPERE) coordinator 1˙854˙562.00

Map

 Project objective

Currently, cancer tumor removal operation is based on preoperative imaging and postoperative pathological examination. There is a strong global trend towards more tissue-sparing and minimally invasive surgery. If all cancer is not removed in the operation, a reoperation is needed, leading to additional costs, impaired cost-effectiveness and impaired quality of life of the patient. The rate of incomplete removal of a tumor ranges from 10-60%. The breakthrough innovative Olfactomics device allows the surgeon to analyze the operated tissue in real-time during cancer surgery leading to optimal tissue removal without compromising the workflow of the operation and facilitating the use of existing instrumentation. The solution is based on noninvasive, real-time analysis of surgical smoke. The reduced reoperation rate results in significant benefits for the patient, surgeon, hospital and society. The market potential is high. Easily reachable market for the breast cancer surgery is 850M€ and market for other applicable specialties (such as prostate cancer, skin cancer, and intestinal surgery) is over 2,000M€. Olfactomics Oy is a Finnish university-based spinoff company founded in 2015 to commercialize the results of over 10 years of clinical and technical research. The team consists of 13 specialists in surgery, medical technology, software, data analysis, financials and law. The team has excellent connections in the international healthcare industry and sensor technology industry. The technology is currently at TRL 7. The first commercial product for research use will be launched in 2019. This project will focus on scale-up to Olfactomics medical device on breast cancer surgery. The impacts by 2027 include: 3,000 Olfactomics devices sold; 300,000 Olfactomics breast cancer surgeries performed, 70,000 women saved from reoperation, 900M€ costs savings in health care, 100M€ revenue and 200 direct workplaces generated. Scale-up to several surgical areas will follow.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OLFACTOMICS SURGERY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OLFACTOMICS SURGERY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Click and Spray (2020)

A SIMPLER, CHEAPER AND EASIER TO RECYCLE AEROSOL CONTAINER

Read More  

CAARESYS (2019)

CAARESYS: vehicle passenger monitoring system based on contactless low emission radio frequency radar.

Read More